aod9604 clinical trials safety side effects AOD-9604 Profile: What Show AOD 9604 With Retatrutide: Evidence,

Instead, AOD 9604 is used to study downstream metabolic processes, particularly adipose tissue signaling and lipid metabolism, without activating the broader endocrine cascade associated with the GH axis

In stock Disclaimer: THIS PRODUCT, SOLD BY LOTI LABS, IS INTENDED AS A RESEARCH CHEMICAL ONLY

It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration

Retatrutide hits the GLP-1, GIP, and glucagon receptors, which is a complementary mechanism to the lipolytic fragment

John DiBella Published: November 3, 2025 Fact-checked by Dr